Oneness Biotech Co Ltd (4743) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Based on the latest financial reports, Oneness Biotech Co Ltd (4743) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$14.32 Million ≈ $451.28K USD) by net assets (NT$10.97 Billion ≈ $345.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Oneness Biotech Co Ltd net asset quality index to measure how much of total assets are equity-financed.

Oneness Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Oneness Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Oneness Biotech Co Ltd to evaluate the quality of earnings relative to operating cash generation.

Oneness Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Oneness Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Formosa International Hotels Corp TW:2707	0.139x
ORIENT SECUR.CO.LTD.H YC1 F:OS9	0.133x
Shanghai Bolex Food Technology Co. Ltd. SHG:603170	N/A
Beta Bionics, Inc. Common Stock NASDAQ:BBNX	-0.088x
Aeon Credit Service Bhd KLSE:5139	-0.076x
SS Innovations International Inc. Common Stock NASDAQ:SSII	-0.042x
Daheng New Epoch Technology Inc SHG:600288	0.025x
Jiangsu Yawei Machine Tool Co Ltd SHE:002559	0.058x

Annual Cash Flow Conversion Efficiency for Oneness Biotech Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Oneness Biotech Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Oneness Biotech Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$12.80 Billion ≈ $403.27 Million	NT$-345.58 Million ≈ $-10.89 Million	-0.027x	+0.94%
2023-12-31	NT$14.50 Billion ≈ $456.74 Million	NT$-395.13 Million ≈ $-12.45 Million	-0.027x	+53.97%
2022-12-31	NT$14.88 Billion ≈ $468.80 Million	NT$-881.00 Million ≈ $-27.76 Million	-0.059x	-188.75%
2021-12-31	NT$14.09 Billion ≈ $443.89 Million	NT$-288.89 Million ≈ $-9.10 Million	-0.021x	-278.41%
2020-12-31	NT$13.76 Billion ≈ $433.50 Million	NT$158.14 Million ≈ $4.98 Million	0.011x	+134.81%
2019-12-31	NT$6.46 Billion ≈ $203.48 Million	NT$-213.25 Million ≈ $-6.72 Million	-0.033x	-1295.85%
2018-12-31	NT$2.17 Billion ≈ $68.23 Million	NT$-5.12 Million ≈ $-161.40K	-0.002x	+96.43%
2017-12-31	NT$2.49 Billion ≈ $78.60 Million	NT$-165.27 Million ≈ $-5.21 Million	-0.066x	-54.05%
2016-12-31	NT$2.52 Billion ≈ $79.53 Million	NT$-108.54 Million ≈ $-3.42 Million	-0.043x	+16.46%
2015-12-31	NT$2.77 Billion ≈ $87.13 Million	NT$-142.34 Million ≈ $-4.48 Million	-0.051x	+34.05%
2014-12-31	NT$1.93 Billion ≈ $60.95 Million	NT$-150.98 Million ≈ $-4.76 Million	-0.078x	-71.90%
2013-12-31	NT$1.97 Billion ≈ $61.94 Million	NT$-89.26 Million ≈ $-2.81 Million	-0.045x	-364.04%
2012-12-31	NT$1.40 Billion ≈ $44.26 Million	NT$24.15 Million ≈ $760.95K	0.017x	+180.32%
2011-12-31	NT$1.37 Billion ≈ $43.07 Million	NT$-29.27 Million ≈ $-922.04K	-0.021x	-115.21%
2010-12-31	NT$1.09 Billion ≈ $34.31 Million	NT$153.25 Million ≈ $4.83 Million	0.141x	+252.19%
2009-12-31	NT$1.11 Billion ≈ $34.86 Million	NT$-102.30 Million ≈ $-3.22 Million	-0.092x	--

About Oneness Biotech Co Ltd

TWO:4743 Taiwan Biotechnology

Market Cap

$720.49 Million

NT$22.87 Billion TWD

Market Cap Rank

#10185 Global

#351 in Taiwan

Share Price

NT$47.80

Change (1 day)

-1.65%

52-Week Range

NT$47.55 - NT$78.50

All Time High

NT$395.32